A Targeted Analysis of Serial Cytokine Measures and Nonpulmonary Organ System Failure in Children With Acute Respiratory Failure: Individual Measures and Trajectories Over Time.


Journal

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies
ISSN: 1529-7535
Titre abrégé: Pediatr Crit Care Med
Pays: United States
ID NLM: 100954653

Informations de publication

Date de publication:
01 09 2023
Historique:
pmc-release: 01 09 2024
medline: 6 9 2023
pubmed: 17 5 2023
entrez: 17 5 2023
Statut: ppublish

Résumé

There is a need for research exploring the temporal trends of nonpulmonary organ dysfunction (NPOD) and biomarkers in order to identify unique predictive or prognostic phenotypes. We examined the associations between the number and trajectories of NPODs and plasma biomarkers of early and late inflammatory cascade activation, specifically plasma interleukin-1 receptor antagonist (IL-1ra) and interleukin-8 (IL-8), respectively, in the setting of acute respiratory failure (ARF). Secondary analysis of the Randomized Evaluation for Sedation Titration for Respiratory Failure clinical trial and Biomarkers in Acute Lung Injury (BALI) ancillary study. Multicenter. Intubated pediatric patients with ARF. NPODs were evaluated against plasma IL-1ra and IL-8 levels on individual days (1 to 4 d after intubation) and longitudinally across days. Within the BALI cohort, 432 patients had at least one value for IL-1ra or IL-8 within days 0 through 5. 36.6% had a primary diagnosis of pneumonia, 18.5% had a primary diagnosis of sepsis and 8.1% died. Multivariable logistic regression models showed that increasing levels of both plasma IL-1ra and IL-8 were statistically significantly associated with increasing numbers of NPODs (IL-1ra: days 1-3; IL-8: days 1-4), independent of sepsis diagnosis, severity of oxygenation defect, age, and race/ethnicity. Longitudinal trajectory analysis identified four distinct NPOD trajectories and seven distinct plasma IL-1ra and IL-8 trajectories. Multivariable ordinal logistic regression revealed that specific IL-1ra and IL-8 trajectory groups were associated with greater NPOD trajectory group ( p = 0.004 and p < 0.0001, respectively), independent of severity of oxygenation defect, age, sepsis diagnosis, and race/ethnicity. Both the inflammatory biomarkers and number of NPODs exhibit distinct trajectories over time with strong associations with one another. These biomarkers and their trajectory patterns may be useful in evaluating the severity of multiple organ dysfunction syndrome in critically ill children and identifying those phenotypes with time-sensitive, treatable traits.

Identifiants

pubmed: 37195096
doi: 10.1097/PCC.0000000000003286
pii: 00130478-990000000-00206
pmc: PMC10524322
mid: NIHMS1891141
doi:

Substances chimiques

Cytokines 0
Interleukin-8 0
Interleukin 1 Receptor Antagonist Protein 0
Biomarkers 0

Types de publication

Multicenter Study Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

727-737

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL095410
Pays : United States

Investigateurs

Scot T Bateman (ST)
M D Berg (MD)
Santiago Borasino (S)
G Kris Bysani (GK)
Allison S Cowl (AS)
Cindy Darnell Bowens (CD)
E Vincent (E)
S Faustino (S)
Lori D Fineman (LD)
A J Godshall (AJ)
Ellie Hirshberg (E)
Aileen L Kirby (AL)
Gwenn E McLaughlin (GE)
Shivanand Medar (S)
Phineas P Oren (PP)
James B Schneider (JB)
Adam J Schwarz (AJ)
Thomas P Shanley (TP)
Lauren R Source (LR)
Edward J Truemper (EJ)
Michele A Vander Heyden (MA)
Kim Wittmayer (K)
Athena Zuppa (A)
David Wypij (D)

Informations de copyright

Copyright © 2023 by the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

Déclaration de conflit d'intérêts

Drs. Dahmer’s, Quasney’s, Curley’s, and Flori’s institutions received funding from the National Heart, Lung, and Blood Institute. Dr. Dahmer’s institution received funding from the National Institute of Child Health and Human Development. Drs. Dahmer, Quasney, Sapru, Curley, and Flori received support for article research from the National Institutes of Health. Dr. Flori disclosed that she is a Board member of Michigan Thoracic Society, Executive Committee Board member of Pediatric Acute Lung Injury and Sepsis Investigators, Taskforce member for Lancet, and a Taskforce member for Society of Critical Care Medicine. The remaining authors have disclosed that they do not have any potential conflicts of interest.

Références

J Crit Care. 2015 Feb;30(1):219.e1-7
pubmed: 25261280
Pediatr Crit Care Med. 2007 Jul;8(4):317-23
pubmed: 17545931
Crit Care. 2019 Apr 17;23(1):128
pubmed: 30995942
Chest. 2015 Jun;147(6):1539-1548
pubmed: 26033126
Am J Respir Crit Care Med. 1997 Apr;155(4):1469-73
pubmed: 9105096
Immunol Rev. 2018 Jan;281(1):8-27
pubmed: 29247995
Comput Methods Programs Biomed. 2011 Apr;102(1):75-80
pubmed: 21146248
Crit Care Med. 2010 Jun;38(6):1436-41
pubmed: 20386309
JAMA. 2015 Jan 27;313(4):379-89
pubmed: 25602358
Crit Care Med. 2012 Apr;40(4):1309-16
pubmed: 22202709
Front Med (Lausanne). 2020 Feb 25;7:46
pubmed: 32161760
Pediatr Crit Care Med. 2017 Apr;18(4):319-329
pubmed: 28212163
Ann Intern Med. 1996 Aug 1;125(3):191-6
pubmed: 8686976
Pediatr Crit Care Med. 2018 Oct;19(10):930-938
pubmed: 30095747
Pediatr Crit Care Med. 2017 Mar;18(3_suppl Suppl 1):S4-S16
pubmed: 28248829
Crit Care Med. 1994 Apr;22(4):673-9
pubmed: 8143477
Crit Care Med. 2018 Mar;46(3):e242-e249
pubmed: 29252929
Am J Respir Crit Care Med. 2005 May 1;171(9):995-1001
pubmed: 15618461
Crit Care Med. 2005 Jan;33(1):1-6; discussion 230-2
pubmed: 15644641
Crit Care. 2022 May 7;26(1):128
pubmed: 35526000
Pediatrics. 2022 Jan 1;149(1 Suppl 1):S1-S12
pubmed: 34970673
Crit Care Med. 2017 May;45(5):858-866
pubmed: 28248715
Crit Care Med. 2012 Dec;40(12):3238-45
pubmed: 22990455
Pediatr Crit Care Med. 2015 Jun;16(5 Suppl 1):S41-50
pubmed: 26035363
Am J Respir Crit Care Med. 2001 Nov 15;164(10 Pt 1):1896-903
pubmed: 11734443
Crit Care Med. 2018 Jan;46(1):21-28
pubmed: 28991823
Crit Care. 2013 Oct 24;17(5):R253
pubmed: 24156650

Auteurs

Silvia M Ardila (SM)

Division of Pediatric Critical Care Medicine, Department of Pediatrics, University of Michigan, Ann Arbor, MI.

Heidi M Weeks (HM)

Department of Nutritional Sciences, University of Michigan School of Public Health, Ann Arbor, MI.

Mary K Dahmer (MK)

Division of Pediatric Critical Care Medicine, Department of Pediatrics, University of Michigan, Ann Arbor, MI.

Niko Kaciroti (N)

Center for Human Growth and Development, University of Michigan, Ann Arbor, MI.
Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, MI.

Michael Quasney (M)

Division of Pediatric Critical Care Medicine, Department of Pediatrics, University of Michigan, Ann Arbor, MI.

Anil Sapru (A)

Department of Pediatrics, University of California, Los Angeles, Los Angeles, CA.

Martha A Q Curley (MAQ)

Division of Pediatric Critical Care Medicine, Department of Pediatrics, University of Michigan, Ann Arbor, MI.
Department of Nutritional Sciences, University of Michigan School of Public Health, Ann Arbor, MI.
Center for Human Growth and Development, University of Michigan, Ann Arbor, MI.
Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, MI.
Department of Pediatrics, University of California, Los Angeles, Los Angeles, CA.
Family and Community Health, School of Nursing, University of Pennsylvania, Philadelphia, PA.
Anesthesia and Critical Care Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Research Institute, Children's Hospital of Philadelphia, Philadelphia, PA.

Heidi R Flori (HR)

Division of Pediatric Critical Care Medicine, Department of Pediatrics, University of Michigan, Ann Arbor, MI.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH